TrialEndocrine-related cancer2024

Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy.

Marcia S Brose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.